0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Metabolomics Market Research Report 2023
Published Date: June 2023
|
Report Code: QYRE-Auto-18M2741
Home | Market Reports | Science
Global Metabolomics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Metabolomics Market Research Report 2023

Code: QYRE-Auto-18M2741
Report
June 2023
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Metabolomics Market Size

According to QYResearch’s new survey, global Metabolomics market is projected to reach US$ 4868.7 million in 2029, increasing from US$ 2136 million in 2022, with the CAGR of 12.9% during the period of 2023 to 2029.

Metabolomics Market

Metabolomics Market

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Metabolomics market research.
The key manufacturers of Metabolomics include Thermo Fisher, Agilent, Metabolon, Shimadzu, Corporation, Bruker, Waters Corporation, etc. Among them, Thermo Fisher and Agilent rank first and second in the world market share, about 12% and 9% respectively.
The market of metabolomics is distributed all over the world, with North America, Europe and Asia Pacific as the major markets. The North American market share reached more than 40%, ranking first in the world.
In terms of product, it include Metabolomics Instruments as well as Bioinformatics Tools and Services. The world market share of the two parts is about 2:1. It is expected that Bioinformatics Tools and Services' market share will increase relatively in the future.
Metabolomics is mainly used in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other institutional organizations. Among them, academic and research institutions occupy the highest market share, accounting for more than 45%. In the Chinese market, the share of academic and research institutions has reached more than 50%.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Metabolomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Metabolomics Market Report

Report Metric Details
Report Name Metabolomics Market
Accounted market size in 2022 US$ 2136 million
Forecasted market size in 2029 US$ 4868.7 million
CAGR 12.9%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Metabolomics Instruments
  • Bioinformatics Tools and Services
Segment by End User
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher, Agilent, Metabolon, Shimadzu Corporation, Bruker, Waters Corporation, Biotree, LECO Corporation, Biocrates Life Sciences AG, Human Metabolome Technologies, Metware, Applied Protein Technology, Creative Proteomics, Diagnostic Solutions Laboratory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Metabolomics Market market growing?

Ans: The Metabolomics Market market witnessing a CAGR of 12.9% during the forecast period 2023-2029.

What is the Metabolomics Market market size in 2029?

Ans: According to QYResearch’s new survey, global Metabolomics market is projected to reach US$ 4868.7 million in 2029, increasing from US$ 2136 million in 2022, with the CAGR of 12.9% during the period of 2023 to 2029.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolomics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Metabolomics Instruments
1.2.3 Bioinformatics Tools and Services
1.3 Market by End User
1.3.1 Global Metabolomics Market Growth by End User: 2018 VS 2022 VS 2029
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metabolomics Market Perspective (2018-2029)
2.2 Metabolomics Growth Trends by Region
2.2.1 Global Metabolomics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Metabolomics Historic Market Size by Region (2018-2023)
2.2.3 Metabolomics Forecasted Market Size by Region (2024-2029)
2.3 Metabolomics Market Dynamics
2.3.1 Metabolomics Industry Trends
2.3.2 Metabolomics Market Drivers
2.3.3 Metabolomics Market Challenges
2.3.4 Metabolomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolomics Players by Revenue
3.1.1 Global Top Metabolomics Players by Revenue (2018-2023)
3.1.2 Global Metabolomics Revenue Market Share by Players (2018-2023)
3.2 Global Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolomics Revenue
3.4 Global Metabolomics Market Concentration Ratio
3.4.1 Global Metabolomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Revenue in 2022
3.5 Metabolomics Key Players Head office and Area Served
3.6 Key Players Metabolomics Product Solution and Service
3.7 Date of Enter into Metabolomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolomics Breakdown Data by Type
4.1 Global Metabolomics Historic Market Size by Type (2018-2023)
4.2 Global Metabolomics Forecasted Market Size by Type (2024-2029)
5 Metabolomics Breakdown Data by End User
5.1 Global Metabolomics Historic Market Size by End User (2018-2023)
5.2 Global Metabolomics Forecasted Market Size by End User (2024-2029)
6 North America
6.1 North America Metabolomics Market Size (2018-2029)
6.2 North America Metabolomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Metabolomics Market Size by Country (2018-2023)
6.4 North America Metabolomics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metabolomics Market Size (2018-2029)
7.2 Europe Metabolomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Metabolomics Market Size by Country (2018-2023)
7.4 Europe Metabolomics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolomics Market Size (2018-2029)
8.2 Asia-Pacific Metabolomics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Metabolomics Market Size by Region (2018-2023)
8.4 Asia-Pacific Metabolomics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metabolomics Market Size (2018-2029)
9.2 Latin America Metabolomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Metabolomics Market Size by Country (2018-2023)
9.4 Latin America Metabolomics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolomics Market Size (2018-2029)
10.2 Middle East & Africa Metabolomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Metabolomics Market Size by Country (2018-2023)
10.4 Middle East & Africa Metabolomics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Metabolomics Introduction
11.1.4 Thermo Fisher Revenue in Metabolomics Business (2018-2023)
11.1.5 Thermo Fisher Recent Development
11.2 Agilent
11.2.1 Agilent Company Detail
11.2.2 Agilent Business Overview
11.2.3 Agilent Metabolomics Introduction
11.2.4 Agilent Revenue in Metabolomics Business (2018-2023)
11.2.5 Agilent Recent Development
11.3 Metabolon
11.3.1 Metabolon Company Detail
11.3.2 Metabolon Business Overview
11.3.3 Metabolon Metabolomics Introduction
11.3.4 Metabolon Revenue in Metabolomics Business (2018-2023)
11.3.5 Metabolon Recent Development
11.4 Shimadzu Corporation
11.4.1 Shimadzu Corporation Company Detail
11.4.2 Shimadzu Corporation Business Overview
11.4.3 Shimadzu Corporation Metabolomics Introduction
11.4.4 Shimadzu Corporation Revenue in Metabolomics Business (2018-2023)
11.4.5 Shimadzu Corporation Recent Development
11.5 Bruker
11.5.1 Bruker Company Detail
11.5.2 Bruker Business Overview
11.5.3 Bruker Metabolomics Introduction
11.5.4 Bruker Revenue in Metabolomics Business (2018-2023)
11.5.5 Bruker Recent Development
11.6 Waters Corporation
11.6.1 Waters Corporation Company Detail
11.6.2 Waters Corporation Business Overview
11.6.3 Waters Corporation Metabolomics Introduction
11.6.4 Waters Corporation Revenue in Metabolomics Business (2018-2023)
11.6.5 Waters Corporation Recent Development
11.7 Biotree
11.7.1 Biotree Company Detail
11.7.2 Biotree Business Overview
11.7.3 Biotree Metabolomics Introduction
11.7.4 Biotree Revenue in Metabolomics Business (2018-2023)
11.7.5 Biotree Recent Development
11.8 LECO Corporation
11.8.1 LECO Corporation Company Detail
11.8.2 LECO Corporation Business Overview
11.8.3 LECO Corporation Metabolomics Introduction
11.8.4 LECO Corporation Revenue in Metabolomics Business (2018-2023)
11.8.5 LECO Corporation Recent Development
11.9 Biocrates Life Sciences AG
11.9.1 Biocrates Life Sciences AG Company Detail
11.9.2 Biocrates Life Sciences AG Business Overview
11.9.3 Biocrates Life Sciences AG Metabolomics Introduction
11.9.4 Biocrates Life Sciences AG Revenue in Metabolomics Business (2018-2023)
11.9.5 Biocrates Life Sciences AG Recent Development
11.10 Human Metabolome Technologies
11.10.1 Human Metabolome Technologies Company Detail
11.10.2 Human Metabolome Technologies Business Overview
11.10.3 Human Metabolome Technologies Metabolomics Introduction
11.10.4 Human Metabolome Technologies Revenue in Metabolomics Business (2018-2023)
11.10.5 Human Metabolome Technologies Recent Development
11.11 Metware
11.11.1 Metware Company Detail
11.11.2 Metware Business Overview
11.11.3 Metware Metabolomics Introduction
11.11.4 Metware Revenue in Metabolomics Business (2018-2023)
11.11.5 Metware Recent Development
11.12 Applied Protein Technology
11.12.1 Applied Protein Technology Company Detail
11.12.2 Applied Protein Technology Business Overview
11.12.3 Applied Protein Technology Metabolomics Introduction
11.12.4 Applied Protein Technology Revenue in Metabolomics Business (2018-2023)
11.12.5 Applied Protein Technology Recent Development
11.13 Creative Proteomics
11.13.1 Creative Proteomics Company Detail
11.13.2 Creative Proteomics Business Overview
11.13.3 Creative Proteomics Metabolomics Introduction
11.13.4 Creative Proteomics Revenue in Metabolomics Business (2018-2023)
11.13.5 Creative Proteomics Recent Development
11.14 Diagnostic Solutions Laboratory
11.14.1 Diagnostic Solutions Laboratory Company Detail
11.14.2 Diagnostic Solutions Laboratory Business Overview
11.14.3 Diagnostic Solutions Laboratory Metabolomics Introduction
11.14.4 Diagnostic Solutions Laboratory Revenue in Metabolomics Business (2018-2023)
11.14.5 Diagnostic Solutions Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Metabolomics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Metabolomics Instruments
    Table 3. Key Players of Bioinformatics Tools and Services
    Table 4. Global Metabolomics Market Size Growth by End User (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Metabolomics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Metabolomics Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Metabolomics Market Share by Region (2018-2023)
    Table 8. Global Metabolomics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Metabolomics Market Share by Region (2024-2029)
    Table 10. Metabolomics Market Trends
    Table 11. Metabolomics Market Drivers
    Table 12. Metabolomics Market Challenges
    Table 13. Metabolomics Market Restraints
    Table 14. Global Metabolomics Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Metabolomics Market Share by Players (2018-2023)
    Table 16. Global Top Metabolomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics as of 2022)
    Table 17. Ranking of Global Top Metabolomics Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Metabolomics Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Metabolomics Product Solution and Service
    Table 21. Date of Enter into Metabolomics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Metabolomics Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Metabolomics Revenue Market Share by Type (2018-2023)
    Table 25. Global Metabolomics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Metabolomics Revenue Market Share by Type (2024-2029)
    Table 27. Global Metabolomics Market Size by End User (2018-2023) & (US$ Million)
    Table 28. Global Metabolomics Revenue Market Share by End User (2018-2023)
    Table 29. Global Metabolomics Forecasted Market Size by End User (2024-2029) & (US$ Million)
    Table 30. Global Metabolomics Revenue Market Share by End User (2024-2029)
    Table 31. North America Metabolomics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Metabolomics Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Metabolomics Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Metabolomics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Metabolomics Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Metabolomics Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Metabolomics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Metabolomics Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Metabolomics Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Metabolomics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Metabolomics Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Metabolomics Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Metabolomics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Metabolomics Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Metabolomics Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Thermo Fisher Company Detail
    Table 47. Thermo Fisher Business Overview
    Table 48. Thermo Fisher Metabolomics Product
    Table 49. Thermo Fisher Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 50. Thermo Fisher Recent Development
    Table 51. Agilent Company Detail
    Table 52. Agilent Business Overview
    Table 53. Agilent Metabolomics Product
    Table 54. Agilent Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 55. Agilent Recent Development
    Table 56. Metabolon Company Detail
    Table 57. Metabolon Business Overview
    Table 58. Metabolon Metabolomics Product
    Table 59. Metabolon Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 60. Metabolon Recent Development
    Table 61. Shimadzu Corporation Company Detail
    Table 62. Shimadzu Corporation Business Overview
    Table 63. Shimadzu Corporation Metabolomics Product
    Table 64. Shimadzu Corporation Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 65. Shimadzu Corporation Recent Development
    Table 66. Bruker Company Detail
    Table 67. Bruker Business Overview
    Table 68. Bruker Metabolomics Product
    Table 69. Bruker Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 70. Bruker Recent Development
    Table 71. Waters Corporation Company Detail
    Table 72. Waters Corporation Business Overview
    Table 73. Waters Corporation Metabolomics Product
    Table 74. Waters Corporation Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 75. Waters Corporation Recent Development
    Table 76. Biotree Company Detail
    Table 77. Biotree Business Overview
    Table 78. Biotree Metabolomics Product
    Table 79. Biotree Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 80. Biotree Recent Development
    Table 81. LECO Corporation Company Detail
    Table 82. LECO Corporation Business Overview
    Table 83. LECO Corporation Metabolomics Product
    Table 84. LECO Corporation Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 85. LECO Corporation Recent Development
    Table 86. Biocrates Life Sciences AG Company Detail
    Table 87. Biocrates Life Sciences AG Business Overview
    Table 88. Biocrates Life Sciences AG Metabolomics Product
    Table 89. Biocrates Life Sciences AG Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 90. Biocrates Life Sciences AG Recent Development
    Table 91. Human Metabolome Technologies Company Detail
    Table 92. Human Metabolome Technologies Business Overview
    Table 93. Human Metabolome Technologies Metabolomics Product
    Table 94. Human Metabolome Technologies Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 95. Human Metabolome Technologies Recent Development
    Table 96. Metware Company Detail
    Table 97. Metware Business Overview
    Table 98. Metware Metabolomics Product
    Table 99. Metware Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 100. Metware Recent Development
    Table 101. Applied Protein Technology Company Detail
    Table 102. Applied Protein Technology Business Overview
    Table 103. Applied Protein Technology Metabolomics Product
    Table 104. Applied Protein Technology Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 105. Applied Protein Technology Recent Development
    Table 106. Creative Proteomics Company Detail
    Table 107. Creative Proteomics Business Overview
    Table 108. Creative Proteomics Metabolomics Product
    Table 109. Creative Proteomics Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 110. Creative Proteomics Recent Development
    Table 111. Diagnostic Solutions Laboratory Company Detail
    Table 112. Diagnostic Solutions Laboratory Business Overview
    Table 113. Diagnostic Solutions Laboratory Metabolomics Product
    Table 114. Diagnostic Solutions Laboratory Revenue in Metabolomics Business (2018-2023) & (US$ Million)
    Table 115. Diagnostic Solutions Laboratory Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metabolomics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Metabolomics Market Share by Type: 2022 VS 2029
    Figure 3. Metabolomics Instruments Features
    Figure 4. Bioinformatics Tools and Services Features
    Figure 5. Global Metabolomics Market Size Comparison by End User (2023-2029) & (US$ Million)
    Figure 6. Global Metabolomics Market Share by End User: 2022 VS 2029
    Figure 7. Academic and Research Institutes Case Studies
    Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
    Figure 9. Contract Research Organizations Case Studies
    Figure 10. Metabolomics Report Years Considered
    Figure 11. Global Metabolomics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Metabolomics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Metabolomics Market Share by Region: 2022 VS 2029
    Figure 14. Global Metabolomics Market Share by Players in 2022
    Figure 15. Global Top Metabolomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Metabolomics Revenue in 2022
    Figure 17. North America Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Metabolomics Market Share by Country (2018-2029)
    Figure 19. United States Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Metabolomics Market Share by Country (2018-2029)
    Figure 23. Germany Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Metabolomics Market Share by Region (2018-2029)
    Figure 31. China Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Metabolomics Market Share by Country (2018-2029)
    Figure 39. Mexico Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Metabolomics Market Share by Country (2018-2029)
    Figure 43. Turkey Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Metabolomics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Thermo Fisher Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 46. Agilent Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 47. Metabolon Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 48. Shimadzu Corporation Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 49. Bruker Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 50. Waters Corporation Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 51. Biotree Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 52. LECO Corporation Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 53. Biocrates Life Sciences AG Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 54. Human Metabolome Technologies Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 55. Metware Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 56. Applied Protein Technology Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 57. Creative Proteomics Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 58. Diagnostic Solutions Laboratory Revenue Growth Rate in Metabolomics Business (2018-2023)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS